Pfizer Inc. (NYSE:PFE) is one of the best dividend stocks to buy, according to hedge funds. On June 24, the US Food and Drug ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Pfizer Inc. said an experimental drug failed to improve survival in patients with an advanced form of lung cancer that couldn ...

Shares of Pfizer Inc. PFE slipped 1.19% to $24.08 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.79% to 7,499.36 and the ...

Pfizer Inc. PFE on Monday reported mixed topline results from its Phase 3 SigVie-002 trial of investigational antibody-drug ...

Pfizer Inc. (NYSE:PFE) is one of the most undervalued NYSE stocks to invest in. On June 18, Pfizer announced that Chief Financial Officer Dave Denton will step down on August 15 to pursue a new ...

Pfizer Inc. forecast little to no sales growth next year as the drugmaker undertakes an effort to refresh its pipeline of hit drugs with a series of pricey acquisitions. Revenue in 2026 will be $59.5 ...

Pfizer Inc. (NYSE:PFE) is among the Best Healthcare Stocks. On June 23, Reuters reported that Pfizer Inc. (NYSE:PFE) ‘s Chief ...

Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here’s a look at what’s going on. What To Know: Pfizer shares are getting a boost after Reuters reported that ...

Editor’s Note: This article has been corrected to reflect that the senators asked UpScriptHealth to respond. In August 2024, Pfizer Inc (NYSE:PFE) introduced the PfizerForAll digital platform in ...